Europe Infectious Disease Diagnostics Market Forecast to 2030

Europe Infectious Disease Diagnostics Market Forecast to 2030

Europe Infectious Disease Diagnostics Market Forecast to 2030 – Regional Analysis – By Product (Kits & Reagents, Instruments, and Software & Services), Technology (Biosensor-Based, Immunodiagnostics, Molecular-Based Diagnostic Techniques, Clinical Biology, and Others), Application Type (Laboratory Testing and Point-of-Care Testing), Testing Type (Human Testing and Veterinary Testing), and End User (Diagnostic Laboratories, Hospitals & Clinics, Research Institutes, Homecare Settings, and Others)

Send Enquiry
Item ID: BMIRE00025318 Category: Tag:

$2,485 – $3,885

Description

The Europe infectious disease diagnostics market was valued at US$ 12,269.57 million in 2022 and is expected to reach US$ 19,029.47 million by 2030; it is estimated to grow at a CAGR of 5.6% from 2022 to 2030.

Rising Application of Diagnostics in Veterinary Infectious Disease Drives Europe Infectious Disease Diagnostics Market

Veterinary infectious diseases negatively impact the health of domestic animals, livestock, and wildlife. As a result of intensive animal farming, there are conditions for the emergence and amplification of disease epidemics due to the genetic and physical proximity of the billions of animals, often in frail health, that are raised indoors every year. Moreover, animal farming contributes to the spread of infections from wild animals due to deforestation caused by the expansion of agricultural land use.

Diagnostic technologies that can detect emerging infectious animal diseases at an early stage are essential to reduce economic losses associated with outbreaks of such diseases. Polymerase chain reaction (PCR) remains the most widely used molecular assay globally to detect animal pathogens. Diagnostic methods of this type are easy to use, cost-effective, susceptible, and specific, with the ability to detect at a high volume.

Even though conventional virological methods are incredibly reliable, they are time-consuming and labor-intensive procedures. Lateral flow and enzyme-linked immunosorbent assay can be used for rapid detection. Multiplex bead immuno or Luminex assay is a fluorescent beads-based high-throughput quantitative technique used for the detection of multiple antibodies specific for different infectious diseases at the same time in a single reaction, leading to more rapid, economical, and accurate results compared with conventional ELISA. In addition, the protein chip based on surface plasmon resonance (SPR) appears to be a rapid valuable tool in the sero-diagnosis of infection or antibody titration. Recombinant antibodies can also be produced in heterologous systems by using rDNA technology and used for developing diagnostic tests.

Point-of-care diagnostics (POCDs) are simple, rapid, and portable diagnostic devices that can detect the disease status at the field level. In recent years, real-time PCR (qPCR) has been transitioned into a POCD platform. These fully automated platforms combine nucleic acid extraction, thermal cycling, and on-site reporting results. For instance, MiniLab from Enigma Diagnostics is a molecular diagnostic platform of 10-35 kg that is carried at the field level and used for validating African swine fever virus, classical swine fever virus, avian influenza virus, and foot-and-mouth disease virus for research purposes. The genesig detection kits of Primerdesign Ltd, UK supply lyophilized qPCR assay kits for the diagnosis of 62 bovine, 42 equine, 47 porcine, 60 avian, 40 canine, and 26 feline pathogens for research purposes. Similarly, Boster offers Bosterbio qPCR kits to detect up to 48 individual or pooled samples. It is used for gene expression profiling, target DNA quantification, microbial detection, viral or bacterial pathogen load determination, and evaluation of primer pair performance for probe-based qPCR. Thus, diagnostics methods such as PCR and qPCR to diagnose bacterial, viral, fungal, and parasitic infections in animals is fueling the diagnostics in veterinary diagnosis.

Europe Infectious Disease Diagnostics Market Overview

According to the data published in an article by the Robert Koch Institute, ~3,900 tuberculosis cases were registered in Germany in 2021. Furthermore, ~5% of the test-site visitors in Germany had STD. Also, the number of annual visitors for chlamydia and gonorrhea tests had increased from 17% (2017) to 42% (2020). According to The Robert Koch Institute, in Germany, approximately 400,000-600,000 patients suffer from HAIs each year; and about 10,000-15,000 of them die due to the infection. Healthcare providers also suffer from various other medical conditions, including surgical site infections, urinary tract infections, and pneumonia.

According to HPV ICO/IARC Information Centre on HPV and Cancer, Fact Sheet 2021, in Germany, ~36.7 million women aged above 15 years are at risk of developing cervical cancer. According to the current estimates, every year, about 4,700 women are diagnosed with cervical cancer, and ~2,100 die from the disease. Cervical cancer is recorded to be the 14th most common type of cancer among women in Germany and the third-most common type of cancer among women between 15 and 44 years of age. About 3.2% of women in the general population are suffering from cervical HPV-16/18 infection at a given time in their lifetime, and ~76.5% of invasive cervical cancers are due to HPVs 16 or 18. The prevalence of various infectious diseases in Germany is fueling the growth of the market in the country.

In March 2022, SCIENION completed PoC-BoSens, the diagnostic research project led by the Fraunhofer Institute for Reliability and Microintegration (IZM). The PoC-BoSens is an innovative label-free Point-of-Care device based on 3-D photonic bottle resonators (3D-BMRs) for accurate measurement of disease-relevant biomolecules. Thus, owing to the above-mentioned factors, the market for infectious disease diagnostics is likely to grow during the forecast period.

Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

Europe Infectious Disease Diagnostics Market Segmentation

The Europe infectious disease diagnostics market is segmented based on product, technology, application type, testing type, end user, and country.

Based on product, the Europe infectious disease diagnostics market is segmented into kits & reagents, instruments, and software & services. The kits & reagents segment held the largest share in 2022.

By technology, the Europe infectious disease diagnostics market is segmented into biosensor-based, immunodiagnostics, molecular-based diagnostic techniques, clinical biology, and others. The immunodiagnostics segment held the largest share in 2022. The immunodiagnostics segment is further subsegmented into enzyme-linked immunosorbent assay (ELISA), western blotting analysis, and immunofluorescence assay. The molecular-based diagnostic techniques segment is further subsegmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), next-generation sequencing (NGS), DNA microarrays, and others.

By application type, the Europe infectious disease diagnostics market is bifurcated into laboratory testing and point-of-care testing. The laboratory testing segment held a larger share in 2022.

By testing type, the Europe infectious disease diagnostics market is bifurcated into human testing and veterinary testing. The human testing segment held a larger share in 2022. The human testing segment is further subsegmented into HIV, hepatitis, HAIs, HPV, tuberculosis, influenza, and others.

By end user, the Europe infectious disease diagnostics market is segmented into diagnostic laboratories, hospitals & clinics, research institutes, homecare settings, and others. The diagnostic laboratories segment held the largest share in 2022.

Based on country, the Europe infectious disease diagnostics market is segmented into Germany, the UK, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe infectious disease diagnostics market in 2022.

Abbott Laboratories, Bruker Corp, Cardinal Health Inc, F. Hoffmann-La Roche Ltd, Trinity Biotech Plc, Danaher Corp, Bio-Rad Laboratories Inc, ACON Laboratories Inc, and DiaSorin SpA are some of the leading companies operating in the Europe infectious disease diagnostics market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

At 5.6% CAGR, the Europe Infectious Disease Diagnostics Market is Speculated to be Worth US$ 19,029.47 Million by 2030, Says the Research Team

According to the Research Team’ research, the Europe infectious disease diagnostics market was valued at US$ 12,269.57 million in 2022 and is expected to reach US$ 19,029.47 million by 2030, registering a CAGR of 5.6% from 2022 to 2030. Rising incidence of infectious diseases and rising application of diagnostics in veterinary infectious disease are among the critical factors attributed to the Europe infectious disease diagnostics market expansion.

Fungi, viruses, parasites, bacteria, and toxic products are among the infectious agents that can cause infectious diseases. Public health is adversely affected by infectious diseases, causing morbidity, mortality, and economic burdens. Rising incidence of infectious diseases propels the requirement for accurate and timely diagnosis to form the basis for effective disease management, treatment, and prevention. Diagnosing and monitoring multiple infections and diseases, including hepatitis C, HIV, tuberculosis, human papillomavirus, and sexually transmitted infections (STIs), and infectious disease outbreaks can be performed using molecular diagnostics techniques, laboratory-based assays, and point-of-care tests.

According to the World Health Organization (WHO), ~58 million people across the world suffer from chronic hepatitis C infection, and ~1.5 million new infections are diagnosed every year. HIV is a major public health issue across the world. According to The Joint United Nations Program on HIV/AIDS (UNAIDS), in 2020, ~ 37.7 million people had HIV. Out of these, ~36 million people were adults, and about 1.7 million were children aged 0-14 years. Also, ~1.5 million new HIV cases were reported globally in 2020.

According to WHO, tuberculosis (TB) is the 13th leading cause of death across the world, and it is the second leading infectious disease that leads to death after COVID-19. According to the WHO, 1.5 million deaths were caused by TB in 2020. In 2020, WHO projected that 10 million people had TB across the world, Furthermore, in 2020, 30 countries with high TB burdens accounted for 86% of new TB cases. Thus, the upsurging incidence of infectious diseases bolsters the need for infectious disease diagnostic technologies, such as microbial culture, hemagglutination inhibition tests, and enzyme-linked immunosorbent assays (ELISA).

On the contrary, inadequate reimbursement scenario hampers the growth of Europe infectious disease diagnostics market.

Based on product, the Europe infectious disease diagnostics market is segmented into kits & reagents, instruments, and software & services. The kits & reagents segment held 69.4% share of the Europe infectious disease diagnostics market in 2022, amassing US$ 8,513.84 million. It is projected to garner US$ 12,991.53 million by 2030 to expand at 5.4% CAGR during 2022-2030.

By technology, the Europe infectious disease diagnostics market is segmented into biosensor-based, immunodiagnostics, molecular-based diagnostic techniques, clinical biology, and others. The immunodiagnostics segment held 45.1% share of the Europe infectious disease diagnostics market in 2022, amassing US$ 5,534.79 million. It is projected to garner US$ 8,310.31 million by 2030 to expand at 5.2% CAGR during 2022-2030. The immunodiagnostics segment is further subsegmented into enzyme-linked immunosorbent assay (ELISA), western blotting analysis, and immunofluorescence assay. The molecular-based diagnostic techniques segment is further subsegmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), next-generation sequencing (NGS), DNA microarrays, and others.

By application type, the Europe infectious disease diagnostics market is bifurcated into laboratory testing and point-of-care testing. The laboratory testing segment held 83.6% share of the Europe infectious disease diagnostics market in 2022, amassing US$ 10,259.80 million. It is projected to garner US$ 15,562.49 million by 2030 to expand at 5.3% CAGR during 2022-2030.

By testing type, the Europe infectious disease diagnostics market is bifurcated into human testing and veterinary testing. The human testing segment held 88.2% share of the Europe infectious disease diagnostics market in 2022, amassing US$ 10,821.74 million. It is projected to garner US$ 16,327.53 million by 2030 to expand at 5.3% CAGR during 2022-2030. The human testing segment is further subsegmented into HIV, hepatitis, HAIs, HPV, tuberculosis, influenza, and others.

By end user, the Europe infectious disease diagnostics market is segmented into diagnostic laboratories, hospitals & clinics, research institutes, homecare settings, and others. The diagnostic laboratories segment held 42.3% share of the Europe infectious disease diagnostics market in 2022, amassing US$ 5,189.85 million. It is projected to garner US$ 8,246.09 million by 2030 to expand at 6.0% CAGR during 2022-2030.

Based on country, the Europe infectious disease diagnostics market is segmented into Germany, the UK, France, Spain, Italy, and the Rest of Europe. Germany held 29.2% share of Europe infectious disease diagnostics market in 2022, amassing US$ 3,579.03 million. It is projected to garner US$ 5,413.88 million by 2030 to expand at 5.3% CAGR during 2022-2030.

Key players operating in the Europe infectious disease diagnostics market are Abbott Laboratories, Bruker Corp, Cardinal Health Inc, F. Hoffmann-La Roche Ltd, Trinity Biotech Plc, Danaher Corp, Bio-Rad Laboratories Inc, ACON Laboratories Inc, and DiaSorin SpA, among others.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe infectious disease diagnostics market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Europe infectious disease diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the infectious disease diagnostics market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution

TABLE OF CONTENTS

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Europe Infectious Disease Diagnostics Market, by Geography (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Infectious Disease Diagnostics Market – Key Industry Dynamics
4.1 Market Drivers:
4.1.1 Rising Incidence of Infectious Diseases
4.1.2 Rising Application of Diagnostics in Veterinary Infectious Disease
4.2 Market Restraints
4.2.1 Inadequate Reimbursement Scenario
4.3 Market Opportunities
4.3.1 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics
4.4 Future Trends
4.4.1 Rising Number of Product Approvals and Launches
4.5 Impact Analysis:
5. Infectious Disease Diagnostics Market – Europe Market Analysis
5.1 Europe Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 – 2030
6. Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by Product
6.1 Overview
6.2 Europe Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%)
6.3 Kits & Reagents
6.3.1 Overview
6.3.2 Kits & Reagents: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Instruments
6.4.1 Overview
6.4.2 Instruments: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
6.5 Software & Services
6.5.1 Overview
6.5.2 Software & Services: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7. Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by Technology
7.1 Overview
7.2 Europe Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%)
7.3 Biosensor-based
7.3.1 Overview
7.3.2 Biosensor-based: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Immunodiagnostics
7.4.1 Overview
7.4.2 Immunodiagnostics: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
7.5 Molecular-Based Diagnostic Techniques
7.5.1 Overview
7.5.2 Molecular-Based Diagnostic Techniques: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.5.2.1 Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
7.6 Clinical Biology
7.6.1 Overview
7.6.2 Clinical Biology: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by Application Type
8.1 Overview
8.2 Europe Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%)
8.3 Point-of-Care Testing
8.3.1 Overview
8.3.2 Point-of-Care Testing: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Laboratory Testing
8.4.1 Overview
8.4.2 Laboratory Testing: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by Testing Type
9.1 Overview
9.2 Europe Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%)
9.3 Human Testing
9.3.1 Overview
9.3.2 Human Testing: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.3.2.1 Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
9.4 Veterinary Testing
9.4.1 Overview
9.4.2 Veterinary Testing: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 – by End User
10.1 Overview
10.2 Europe Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Diagnostic Laboratories
10.3.1 Overview
10.3.2 Diagnostic Laboratories: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Hospitals and Clinics
10.4.1 Overview
10.4.2 Hospitals and Clinics: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Research Institutes
10.5.1 Overview
10.5.2 Research Institutes: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Homecare Settings
10.6.1 Overview
10.6.2 Homecare Settings: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.7 Others
10.7.1 Overview
10.7.2 Others: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11. Europe Infectious Disease Diagnostics Market – Country Analysis
11.1 Europe Infectious Disease Diagnostics Market – Country Analysis
11.1.1 Europe Infectious Disease Diagnostics Market, by Country
11.1.1.1 UK
11.1.1.1.1 Overview
11.1.1.1.2 UK: Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.1.3 UK: Europe Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.1.1.4 UK: Europe Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.1.1.4.1 UK: Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
11.1.1.1.4.2 UK: Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
11.1.1.1.5 UK: Europe Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
11.1.1.1.6 UK: Europe Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
11.1.1.1.6.1 UK: Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
11.1.1.1.7 UK: Europe Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.1.2 Germany
11.1.1.2.1 Overview
11.1.1.2.2 Germany: Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2.3 Germany: Europe Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.1.2.4 Germany: Europe Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.1.2.4.1 Germany: Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
11.1.1.2.4.2 Germany: Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
11.1.1.2.5 Germany: Europe Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
11.1.1.2.6 Germany: Europe Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
11.1.1.2.6.1 Germany: Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
11.1.1.2.7 Germany: Europe Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.1.3 France
11.1.1.3.1 Overview
11.1.1.3.2 France: Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.3.3 France: Europe Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.1.3.4 France: Europe Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.1.3.4.1 France: Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
11.1.1.3.4.2 France: Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
11.1.1.3.5 France: Europe Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
11.1.1.3.6 France: Europe Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
11.1.1.3.6.1 France: Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
11.1.1.3.7 France: Europe Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.1.4 Italy
11.1.1.4.1 Overview
11.1.1.4.2 Italy: Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.4.3 Italy: Europe Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.1.4.4 Italy: Europe Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.1.4.4.1 Italy: Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
11.1.1.4.4.2 Italy: Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
11.1.1.4.5 Italy: Europe Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
11.1.1.4.6 Italy: Europe Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
11.1.1.4.6.1 Italy: Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
11.1.1.4.7 Italy: Europe Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.1.5 Spain
11.1.1.5.1 Overview
11.1.1.5.2 Spain: Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.5.3 Spain: Europe Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.1.5.4 Spain: Europe Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.1.5.4.1 Spain: Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
11.1.1.5.4.2 Spain: Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
11.1.1.5.5 Spain: Europe Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
11.1.1.5.6 Spain: Europe Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
11.1.1.5.6.1 Spain: Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
11.1.1.5.7 Spain: Europe Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
11.1.1.6 Rest of Europe
11.1.1.6.1 Overview
11.1.1.6.2 Rest of Europe: Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.6.3 Rest of Europe: Europe Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
11.1.1.6.4 Rest of Europe: Europe Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
11.1.1.6.4.1 Rest of Europe: Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
11.1.1.6.4.2 Rest of Europe: Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
11.1.1.6.5 Rest of Europe: Europe Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
11.1.1.6.6 Rest of Europe: Europe Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
11.1.1.6.6.1 Rest of Europe: Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
11.1.1.6.7 Rest of Europe: Europe Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Abbott Laboratories
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Bruker Corp
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Cardinal Health Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Trinity Biotech Plc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Danaher Corp
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Bio-Rad Laboratories Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 ACON Laboratories Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 DiaSorin SpA
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Infectious Disease Diagnostics Market Segmentation
Table 2. Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 3. Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 4. Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 5. UK: Europe Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 6. UK: Europe Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 7. UK: Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 8. UK: Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 9. UK: Europe Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million)
Table 10. UK: Europe Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 11. UK: Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 12. UK: Europe Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 13. Germany: Europe Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 14. Germany: Europe Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 15. Germany: Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 16. Germany: Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 17. Germany: Europe Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million)
Table 18. Germany: Europe Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 19. Germany: Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 20. Germany: Europe Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 21. France: Europe Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 22. France: Europe Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 23. France: Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 24. France: Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 25. France: Europe Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million)
Table 26. France: Europe Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 27. France: Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 28. France: Europe Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 29. Italy: Europe Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 30. Italy: Europe Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 31. Italy: Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 32. Italy: Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 33. Italy: Europe Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million)
Table 34. Italy: Europe Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 35. Italy: Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 36. Italy: Europe Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 37. Spain Europe Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 38. Spain: Europe Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 39. Spain: Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 40. Spain: Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 41. Spain: Europe Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million)
Table 42. Spain: Europe Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 43. Spain Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 44. Spain Europe Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 45. Rest of Europe: Europe Infectious Disease Diagnostics Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 46. Rest of Europe: Europe Infectious Disease Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 47. Rest of Europe: Europe Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 48. Rest of Europe: Europe Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 49. Rest of Europe: Europe Infectious Disease Diagnostics Market, by Application Type – Revenue and Forecast to 2030 (US$ Million)
Table 50. Rest of Europe: Europe Infectious Disease Diagnostics Market, by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 51. Rest of Europe: Europe Infectious Disease Diagnostics Market, for Human Testing by Testing Type – Revenue and Forecast to 2030 (US$ Million)
Table 52. Rest of Europe: Europe Infectious Disease Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 53. Organic Developments Done By Companies
Table 54. Inorganic Developments Done By Companies
Table 55. Glossary of Terms, Europe Infectious Disease Diagnostics Market
 

LIST OF FIGURES

Figure 1. Europe Infectious Disease Diagnostics Market Segmentation, By Country
Figure 2. Europe Infectious Disease Diagnostics Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 – 2030
Figure 5. Europe Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%)
Figure 6. Kits & Reagents: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Instruments: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Software & Services: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%)
Figure 10. Biosensor-based: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Immunodiagnostics: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Molecular-Based Diagnostic Techniques: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Clinical Biology: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Europe Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%)
Figure 16. Point-of-Care Testing: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Laboratory Testing: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Europe Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%)
Figure 19. Human Testing: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Veterinary Testing: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Europe Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 22. Diagnostic Laboratories: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Hospitals and Clinics: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Research Institutes: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Homecare Settings: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Europe Infectious Disease Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Europe Infectious Disease Diagnostics Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 28. Europe Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%)
Figure 29. UK: Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Germany: Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. France: Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Italy: Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 33. Spain: Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 34. Rest of Europe: Europe Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 35. Growth Strategies Done by the Companies in the Market, (%)

The List of Companies – Europe Infectious Disease Diagnostics Market

1. Abbott Laboratories
2. ACON Laboratories Inc
3. Bio-Rad Laboratories Inc
4. Bruker Corp
5. Cardinal Health Inc
6. Danaher Corp
7. DiaSorin SpA
8. F. Hoffmann-La Roche Ltd
9. Trinity Biotech Plc

Reviews

There are no reviews yet.

Be the first to review “Europe Infectious Disease Diagnostics Market Forecast to 2030”